Sage Journals: Discover world-class research

1-10 of 170 results for interferon beta 1a

Sort by:

Relevance

Select allExport selected citations

Sort by:

Relevance

Open access

Research article

First published 2011-4

Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy

Magnhild Sandberg-Wollheim, Enrica Alteri, Margaretha Stam Moraga [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2003-08

Oral interferon beta-1a in relapsing-remitting multiple sclerosis: a double-blind randomized study

C Polman, F Barkhof, L Kappos [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2008-03

Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis

G. Serarslan, EE Okuyucu, IM Melek [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2018-2

Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection

Giancarlo Coghe, Laura Atzori, Jessica Frau [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018-12

Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE

Stanley Cohan, Ludwig Kappos, Gavin Giovannoni [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2010-5

Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study

RA Bermel, B. Weinstock-Guttman, D. Bourdette [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019-1

Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results

Robert T Naismith, Barry Hendin, Sibyl Wray [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Other

First published 2007-11

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b

K. Baum, C. O'Leary, F. Coret Ferrer [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2017-9

Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis

Rafael Arroyo González, Mariko Kita, Heidi Crayton [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2009-06

Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria

P O’Connor, RP Kinkel, M Kremenchutzky

Multiple Sclerosis Journal

Search results